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Even though the production of orthochromatic erythroblasts can be scaled up to fulﬁll clinical requirements, enucleation remains
one of the critical rate-limiting steps in the production of transfusable red blood cells. Mammalian erythrocytes extrude their
nucleus prior to entering circulation, likely to impart ﬂexibility and improve the ability to traverse through capillaries that are half
the size of erythrocytes. Recently, there have been many advances in our understanding of the mechanisms underlying mammalian
erythrocyte enucleation. This review summarizes these advances, discusses the possible future directions in the ﬁeld, and evaluates
the prospects for improved ex vivo production of red blood cells.
1.Introduction
Blood transfusions are a common practice to treat severe
anemia and shock. Even though developed countries by
and large have suﬃcient supplies of transfusable blood,
an increase in the incidence of complications from allo-
genic immune reactions provides impetus to search for
alternatives that are less immunogenic [1–3]. Moreover,
developing and third world countries battle a shortage of
blood units for transfusions [4]. One alternative under
investigation is the ex vivo derivation of red blood cells
from autologous hematopoietic stem/progenitor cells. In
addition to enhancing the supply of transfusable blood, this
approach may decrease the incidence of allogenic immune
reactions in chronic transfusion-dependent patients. Human
embryonic stem cells, CD34+ cells from umbilical cord
blood, adult hematopoietic stem/progenitor cells, peripheral
bloodCD34+cells,orhuman-inducedpluripotentstemcells
(iPScells)canallbeusedassourceforsynthesizingRBCs[5].
In all these systems, however, the eﬃciency of enucleation is
low. Enucleation is an important criterion because nucleated
erythroblasts are not as eﬃc i e n ti no x y g e nt r a n s p o r ta n d
because they are likely to undergo hemolysis as they traverse
through narrow capillaries. Enucleated cells also oﬀer the
beneﬁtoflackingDNAandtheabilitytodivide,obviatingthe
risk of introducing a malignancy into the recipients [6, 7].
Enucleationremainsoneofthecriticalrate-limitingsteps
of in vitro RBC synthesis. Lu et al. achieved 60% enucleation
of erythroblasts derived from human ES cells (hES cells).
The RBCs produced expressed mainly fetal and embryonic
hemoglobin and were comparable to normal RBCs in terms
of oxygen delivery [8]. Recently, Lapillonne et al. have
reported the production of red blood cells from human
iPS cells. Although the majority of the culture consisted of
orthochromatic erythroblasts, enucleated RBCs accounted
for only between 4 and 10% of the culture [9]. Thus, there
is a long way to go in terms of achieving 100% enucleation
in vitro. This review will summarize the current mechanistic
understanding of enucleation, propose a new model, and
discuss future research directions.
2. Deﬁning Erythroblast Enucleation
Mammals have evolved to enucleate their erythroblasts
while other animals maintain circulation of RBCs with
condensed pyknotic nuclei. Of note, however, the circulation
of early mammalian embryos includes nucleated primitive
erythroid cells. These cells mature in the bloodstream
between embryonic days (E) 14.5 and E16.5 of mouse
gestation and eventually enucleate likely within the fetal
liver [10]. Deﬁnitive erythropoiesis, which leads to exclusive2 Stem Cells International
production of enucleated reticulocytes, begins in mid gesta-
tion. RBCs derived from deﬁnitive erythropoiesis originate
in the fetal liver or bone marrow depending upon the age of
the fetus [11].
In all cases, erythroblasts are derived from hematopoietic
stem cells (HSCs). The ﬁrst cell committed towards the
erythroid lineage is the burst forming unit-erythroid (BFU-
E), which further proliferates and matures to the colony-
forming unit E (CFU-E). The BFU-E stage is the most
proliferativesegmentofthediﬀerentiationprogramfollowed
by the CFU-E stage. Acquisition of EPO receptors occur in
the mid-to-late stage of BFU-E, and by the time these cells
reach CFU-E stage maximum numbers of EPO receptors
are present on their surface [12]. During this time period,
cells are completely dependent on erythropoietin (EPO)
for their survival [13]. The CFU-E then undergoes a series
of maturational steps named proerythroblasts, basophilic
erythroblasts, polychromatic erythroblasts, and eventually
orthochromatic erythroblasts, at which point they exit the
cell cycle. By the time, the cells reach late polychromatic
erythroblast stage the cells are independent of EPO for their
survival [14]. Other cytokines and humeral factors that may
be required to promote diﬀerentiation beyond the poly-
chromatic stage has not been identiﬁed although autocrine
production of several cytokines have been observed [15,
16]. Whether these cytokines provide the necessary signals
for terminal diﬀerentiation including enucleation is unclear
at this point. Throughout the diﬀerentiation program,
erythroid progenitors and erythroblasts undergo numerous
morphological changes. These include (1) a decrease in cell
size, (2) nuclear condensation, and (3) an increase in the
cytoplasmic nuclear ratio.
As red cells mature, chromatin becomes condensed,
and transcription in general is suppressed. A network of
chromatin factors and histone modifying proteins likely
contribute to this process. For example, the nonhistone
nuclear protein mature erythrocyte nuclear termination
stage speciﬁc protein (MENT) has been shown to promote
chromatin condensation and nuclear collapse at the terminal
stage of maturation of chicken erythrocytes [17]. Similarly,
the condensin II subunit mCAP-G2 represses transcrip-
tion by recruiting class I histone deacetylases (HDACs)
and promotes terminal diﬀerentiation of mammalian cells
[18]. During maturation of murine erythroblasts, histone
H3(K9) dimethylation was found to increase while his-
tone H4(K12) acetylation was dramatically decreased [19].
Consistent with a requirement for decreased acetylation,
treatment of murine erythroblasts with the HDAC inhibitors
trichostatin A or valproic acid blocked chromatin conden-
sation and enucleation [19, 20]. Moreover, knockdown of
HDAC2 led to a prominent block in condensation and
nuclear extrusion. Recent studies have further revealed that
downregulation of miR-191, which occurs during normal
diﬀerentiation, contributes to chromatin condensation by
allowing the upregulation of Riok3, an atypical protein
kinase, and Mxi1, a c-myc antagonist [21]. Downregu-
lation of myc appears to be required not for cell cycle
arrest, but rather to allow for nuclear condensation and
histone deacetylation [22]. Together these studies show that
chromatin condensation is an integral part of erythroblast
maturation.
After exiting the ﬁnal cell cycle, the nuclei of orthochro-
matic erythroblasts are polarized to one side of the cell.
Eventually these cells enucleate to form reticulocyte and
a “pyrenocyte,” the extruded nucleus with a thin rim of
cytoplasm surrounded by a plasma membrane [10, 23].
Pyrenocytes are engulfed by macrophages in erythroblastic
islands within the fetal liver and bone marrow. During
terminaldiﬀerentiation,cellsundergomultiplecellularproc-
esses including protein sorting, autophagy, membrane mat-
uration, vesicle traﬃcking, and cytoskeletal remodeling.
Important questions to the ﬁeld include the following (1)
To what extent do these processes contribute to enucleation?
(2) Which of these steps are required for enucleation? (3) At
which point in the diﬀerentiation continuum does enucle-
ation start? (4) Can enucleation occur in a cell that is not
completely matured, such as a polychromatic erythroblast?
(5) Can enucleation proceed before nuclear condensation
is completed? At this point, it has not been demonstrated
whether enucleation can occur in an immature erythroblast.
Based on the model that chromatin condensation is a
prerequisite for enucleation [19, 20, 24], however, one
would assume that this is unlikely. Examining the nuclei
engulfed by macrophages within genetically modiﬁed mice
that have a block in maturation of late erythroblasts
may help answer whether enucleation can take place in
erythroblasts other than orthochromatic erythroblasts. Since
nuclear condensation and other morphological changes are
progressive processes that proceed from proerythroblasts
through orthochromatic erythroblasts, and since primitive
RBCs and nucleated peripheral blood RBCs of lower animals
have condensed nuclei, for the purposes of this review, we
will consider enucleation to be a process that begins with
polarization of nucleus in an orthochromatic erythroblast.
3. Mechanism of Enucleation
3.1. Apoptosis, Asymmetric Cytokinesis, or Other?. Histori-
cally there have been two prominent models of enucleation:
apoptosis and asymmetric cytokinesis. The presence of
partial karyolysis and leakage of nuclear material into the
cytoplasm visualized by electron microscopy favors the
apoptosis model [25]. Additional evidence includes the
prevailing model that lens epithelial cells and keratinocytes
undergo a mechanism similar to programmed cell death
to eliminate their nuclei [26, 27]. To directly test this
whether apoptosis is required for enucleation, Carlile et al.
studied the eﬀect of siRNA-mediated caspase knockdown
on enucleation and found that there was a 50% decrease in
enucleated cells in the knockdown condition as compared
to control. However, the authors noted that maturation was
blocked at a stage between proerythroblasts and basophilic
erythroblasts, suggesting a role for caspases at an earlier
stage of erythroblast development [28]. Furthermore, Krauss
et al. observed that critical nuclear structures such as the
nuclear matrix protein NuMA (nuclear mitotic apparatus)
and the splicing factors Sm and SC35, as well as theStem Cells International 3
interaction between lamin B with the nuclear envelope and
DNA persisted during late erythroblast development prior to
enucleation, consistent with an absence of caspase activity
[29]. In addition, treatment of enucleating erythroblasts
with pan-caspase inhibitors did not block enucleation [23].
Together, these ﬁndings strongly suggest that apoptosis is not
involved in enucleation per se.
The cytokinetic model posits that nuclear extrusion is a
form of cell division, in which the nucleus is separated from
the cytoplasm by an active process that involves cytokinetic
machinery. By this deﬁnition, an enucleating cell should
havea well-deﬁnedcleavagefurrow, acontractileactomyosin
ring, and a stage of completion with abscission [30]. Indeed,
many studies including ultra-structural observations from
the 1960s lend support to this model. For example, Skutelsky
and Danon and others noticed that the pyrenocytes had
a thin rim of cytoplasm surrounded by an intact plasma
membrane [23, 25, 31–34], a ﬁnding that conﬁrms that
the nucleus is not extruded out or exocytosed, but rather
separated in a well-orchestrated process. Moreover, one can
see a constricted surface resembling a cleavage furrow on
enucleating erythroblasts [32, 33, 35, 36]. Further, there
are numerous studies showing that cytochalasin D, an
actin-depolymerizing agent which blocks ﬁlamentous actin
formation, inhibits enucleation of late erythroblasts in-vitro
[23, 33, 35, 37]. It has also been shown by immunoﬂuo-
rescence that actin accumulates in the region between the
nucleus and the cytoplasm close to an anatomic constriction
zone [33, 38, 39]. Finally, elegant studies with murine
primaryerythroblastshavedemonstratedthatRac1andRac2
functionthroughmDia2tocontributetoactinaccumulation
in the constriction zone [36]. While these ﬁndings provide
strongevidencetosupportarolefortheactincytoskeletonin
erythroblast maturation, it is unclear regarding the speciﬁc
role actin is playing in enucleation, including whether it
interacts with nonmuscle myosin II to form a contractile
actin ring similar to cytokinesis (Figure 1).
In addition to the actin cytoskeleton, microtubules play
an important role in cell division including cleavage furrow
formation [30]. Studies by Koury et al. showed that the
inhibition of microtubules with various toxins such as
colchicine, vinblastine and taxol did not aﬀect enucleation
[33]. Ji et al. showed that enucleation does not depend on
RhoA activity, using dominant negative mutants of RhoA
and C3 exoenzyme, a speciﬁc inhibitor of RhoA [36]. It
is well known that RhoA is involved in the formation
and ingression of cleavage furrow. RhoA when activated
accumulates in the cleavage furrow and further activates
downstream eﬀectors including Rho kinase (ROCK), citron
kinase,LIMkinase,andformins[40–43].Hencealackofrole
for RhoA and microtubule in enucleation suggests that the
anatomical constriction zone that is visible on enucleating
cell may not be actually a cleavage furrow.
What about intermediate ﬁlaments? Using murine
splenic erythroblasts infected with the anemia-inducing
strain of Friend virus (FVA), Koury et al. found that ery-
throblasts approaching enucleation downregulate expression
of vimentin [33]. Further, Xue et al., using immunoﬂuo-
rescence techniques, observed that vimentin anchored the
nuclearlaminatothecenterofthecellaswellastotheplasma
membrane periphery and was expressed during the periods
of 12, 24, and 36 hours of FVA in vitro culture but lost by 36–
48hours[39].Thislossofvimentincouldreleasethenucleus
and enable actin to push it towards one end of the cell close
to plasma membrane. Of note, circulating avian erythrocytes
continue to have intact vimentin, which might be one of the
reasons why they resist enucleation [44].
To test whether actin functions as contractile actomyosin
ring in nuclear extrusion, Keerthivasan et al. treated pri-
mary murine and human erythroblasts with blebbistatin at
diﬀerent time points and assayed the eﬀect on cell division
and enucleation [34]. Blebbistatin is a speciﬁc nonmuscle
myosin II ATPase inhibitor that blocks the contractility
of the actomyosin ring in cytokinetic cells and results in
polyploidy of dividing cells without aﬀecting the formation
of actin cytoskeleton [45]. Keerthivasan et al. showed that
blebbistatin potently inhibited enucleation when added to
cultures at 24 hours, when the majority of cells were
undergoing cell division. In this case, blebbistatin resulted
in cell cycle arrest and the accumulation of polyploid cells.
In contrast, blebbistatin had little eﬀect on enucleation
when it was added to cells at 38 hours, a time when the
majority of cells are postmitotic [34]. These ﬁndings suggest
that although actin accumulates in the region between the
nucleus and cytoplasm during late stage erythroblasts, its
role as a contractile actomyosin ring similar to cytokinesis
in enucleation is questionable.
Abscission is the ﬁnal stage of cytokinesis and involves
traﬃcking of vesicles to the midbody region and fusion of
these vesicles to lead to separation of the daughter cells [46,
47]. Throughout cytokinesis, membranes are supplied to the
progressing tip of the cleavage furrow and the abscission site
through golgi and recycling endosome-derived vesicles [48,
49]. Several lines of evidence support the model that vesicle
traﬃcking directly contributes to enucleation, in large part
by providing membranes to facilitate the separation of the
pyrenocyte from the reticulocyte. First, electron microscopy
has revealed the presence of vesicles and U-shaped tubes in
the region between the nucleus and incipient reticulocyte
[25, 34, 50]. Second, there is an accumulation of transferrin
ladenvesicles/vacuolesintheregionbetweenthenucleusand
the cytoplasm [34, 50]. Third, disrupting vesicle traﬃcking
by a battery of chemical inhibitors inhibited accumulation
of those vesicles and blocked erythroblast enucleation [34].
Finally, siRNA-mediated knockdown of clathrin inhibited
enucleation of human primary erythroblasts [34]. These
ﬁndings strongly suggest that vesicle traﬃcking is a key
component of erythroblast enucleation and that at least a
part of nuclear extrusion process is similar to abscission
(Figure 1).
3.2. Protein Sorting and Enucleation. An important event
during enucleation is the diﬀerential sorting of proteins
to the pyrenocyte and the reticulocyte. Geiduschek and
Singer studied this phenomenon by an immunoﬂuorescence
technique and followed the distribution of lectin receptors
and spectrin through erythroid diﬀerentiation. They found
that spectrin completely sorts to the incipient reticulocyte4 Stem Cells International
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Figure 1: Key events in cytokinesis and enucleation. Even though the ﬁnal stages of cytokinesis and enucleation are both driven by vesicle
traﬃcking, the preceding events are substantially diﬀerent between the two processes.
while receptors for concanavalin A are restricted to the
plasma membrane surrounding the extruding nucleus [51].
Using murine erythroleukemia (MEL)cells,Pateland Lodish
reported that enucleated cells detach from a ﬁbronectin
matrix due to the loss of the ﬁbronectin receptor while
both Band 3 and ankyrin are enriched in the reticulocyte
[52]. Transferrin has been found to diﬀerentially sort to
the pyrenocyte membrane while glycophorin A/TER119
segregates to the reticulocyte membrane [53, 54]. Inhibition
of vesicle traﬃcking by MiTMAB (dynamin inhibitor)
preventedsortingofthetransferrinreceptor(CD71)towards
pyrenocyte side of membrane of enucleating erythroblasts
[34]. Thus, sorting of proteins and enucleation appear
to be coupled in that both require vesicle traﬃcking.
Primitive erythroblasts also diﬀerentially sort proteins, such
as TER119 (reticulocyte) and α4-integrin (pyrenocyte) in
a manner similar to deﬁnitive erythroblasts [55]. This
diﬀerence in composition of the membranes of pyrenocyte
versus reticulocyte likely assists pyrenocytes to attach to
macrophages while allowing reticulocytes to move into the
circulation.
Further, nuclear positioning, an essential component
of enucleation (Figure 1), can be speculated to depend on
protein sorting and vesicle traﬃcking. Interestingly, the
observations by Skutelsky and Danon [31]a n dJ ie ta l .
[56] about the nuclear positioning supports this notion.
The former group, using ﬁxed sections, noticed that some
erythroblasts were having protrusion of the plasma mem-
brane along with a portion of nuclei. They saw a variety of
sizes of this protrusion, including in some cells the nucleus
completely occupied inside the cavity. Using these pieces
of ﬁxed section observations, they constructed a model in
which the nucleus at ﬁrst occupies an eccentric position
adjacent to the cell membrane and a cytoplasmic protrusion
ensues taking along the nuclei until the protrusion com-
pletely holds the nuclei. Ji et al. observed a similar process
in murine fetal liver erythroblasts using live cell imaging.
These ﬁndings suggest that the visible constriction zone on
the surface of enucleating erythroblast is indeed a junction
region in the plasma membrane that separates pyrenocyte
and reticulocyte membrane. The membrane that is destined
to enclose pyrenocyte that is in close proximity to nucleus
lacks actin cytoskeleton, spectrin, and other critical proteins
and as a result can be visualized to balloon out without
resisting the pressure exerted by the cytoskeletal activity
(Figure 2).Stem Cells International 5
Figure 2: Model of enucleation. A schematic representation of the enucleation process in mammals is shown. Yellow arrows denote the
direction of force applied over the nucleus by actin cytoskeleton. Blue arrows and vesicles denote the protein traﬃcking, which directs the
proteins that are destined to reach the pyrenocyte. The blue membrane adjacent to the nucleus is the part of the pyrenocyte membrane
lacking spectrin, glycophorin A, actin cytoskeleton, and other reticulocyte-speciﬁc proteins that are diﬀerentially sorted. The green arrow
represents the direction of the force exerted on the pyrenocyte by a bound macrophage while the red arrow indicates the movement of the
reticulocyte away from the center by lamellipodia and ﬁlopodia.
3.3. Macrophages and Enucleation. Pyrenocytes gradually
start expressing phosphatidyl serine on their surface, pro-
viding an “eat me” signal for macrophages, which engulf
them [23]. The engulfed nucleus is then digested in lysosome
where DNase II digests the DNA within the engulfed
nuclei [57]. The importance of this pathway for continued
erythropoiesis is highlighted by the phenotype of DNase
II knockout mice, which die in utero due to embryonic
lethal anemia. When DNase II null fetal liver progenitors
are transplanted into lethally irradiated recipients, the pro-
genitors give rise to normal erythrocytes, showing that the
defect is noncell autonomous, attributable to macrophages.
The important role of macrophages in enucleation is also
supported by the phenotype of retinoblastoma (Rb) tumor
suppressor gene knockout mice. Mutant embryos exhibited
a defect in enucleation, which was attributed to a lack of
suppression of Id1 (a helix-loop-helix protein) by Rb in
macrophages [58]. In vivo, deﬁnitive erythropoiesis takes
placewithinerythroblasticislands.Macrophagesresideatthe
center of island, with erythroblasts at various diﬀerentiation
stages layered around the outside [59–61]. Hanspal and
Hanspal found that the interaction between erythroblasts
and macrophages is needed for normal proliferation of
erythroblasts as well as for enucleation [62]. This interaction
is mediated by EMP (erythroblast macrophage protein),
which functions to prevent apoptosis of developing ery-
throblasts [63]. While these studies point to an essential
role for macrophages during erythropoiesis, many groups
have shown that erythroblasts cultured in vitro in the
absence of macrophages undergo complete diﬀerentiation
including nuclear extrusion [16, 64]. Hence we can conclude
that enucleation formally can occur without macrophages.6 Stem Cells International
However, in vivo macrophages appear to play important
functions in enucleation and erythroid homeostasis.
3.4. Autophagy and Enucleation. Another important phe-
nomenon that takes place during enucleation is autophagy, a
process by which cellular components such as organelles and
protein aggregates are catabolized [65–67]. Autophagy pro-
ceeds in multiple steps. First, a double membrane develops
around the cytoplasmic cargo to be degraded by autophagy.
This double membrane can be derived from either the
endoplasmic reticulum [68, 69] or the plasma membrane
[70, 71]. Fusion of these membranes to one other sequesters
the cargo to form an autophagosome, which in turn fuses
with multivesicular body/late endosome/lysosome, leading
to degradation of the cargo and the inner bilayer of
the double-membrane. This vacuole that contains digested
cytosolic contents is called autophagolysosome [72–74].
In erythroblasts, mitochondrial clearance has been
shown to be accomplished through autophagy [75]. Multiple
studies have shown that Nix (Bnip3L), a Bcl-2 family
member, is required for mitochondrial clearance in reticu-
locytes and that loss of Nix leads to anemia [76, 77]. The
lack of clearance has been proposed to be the result of
defective entry of mitochondria into autophagosomes [77–
79]. Although loss of Nix did not aﬀect enucleation [77, 80],
it is interesting to consider the dependence of autophagy
on vesicle traﬃcking. The inhibition of vesicle traﬃcking
blocked formation of autophagolysosomes and resulted in
enucleation defects (G.K, A.W, and JDC, unpublished data).
Further studies on the relationship between autophagy,
vesicle traﬃcking, and enucleation may shed additional light
on erythrocyte maturation.
3.5. Possible Roles of Actin in Enucleation. Actin has multiple
roles in a cell, including cell division, migration, junction
formation, chromatin remodeling, transcriptional regula-
tion, vesicle traﬃcking, and cell shape regulation [81]. In
an enucleating cell, actin could be involved in maintaining
the shape of the cell, and/or in maintenance of polarity
of the nucleus. Actin may also assist in the formation and
movement of endocytic vesicles [82, 83]. Indeed, actin has
been proposed to mediate the short-range movement of
vesicles and may work together with myosins V and VI and
members of the kinesin family [84], to direct vesicles during
enucleation. Actin is regulated by Rac proteins that play a
role in the formation of lamellipodia, ﬁlopodia, membrane
ruﬄes, and cell movement [85] .T a k e nt o g e t h e r ,a c t i nl i k e l y
participates in erythroid maturation by polarization of
nucleus, by promoting the accumulation and coalescence
of vesicles/vacuoles, and by inducing migration of the
reticulocyte away from the pyrenocyte.
4. Model of Enucleation
Erythroblast enucleation is a unique process that incorpo-
rates multiple aspects of cytokinesis and vesicle traﬃcking
(Figure 2). First, one or more cellular signals initiate the
process of enucleation. At least one study suggested that p38
mitogen-activated protein (MAP) kinase (MAPK) signaling
is involved in late erythroid diﬀerentiation and enucleation
[86]. However, if extracellular factors either secreted by the
bone marrow stroma or by erythroblasts themselves play
a role in engaging yet unidentiﬁed receptors to initiate an
intracellular signaling cascade/s leading to the activation
of signaling molecules such as the p38MAP kinase and/or
the Rac-1 GTPase that may begin the enucleation process
is yet to be determined. Once the process is initiated, the
actin cytoskeleton polarizes the condensed nucleus, free
from intermediate ﬁlament attachments, to one side of
the cell. Note that this polarization need not be random,
and there may well exist novel factors that determine the
polarity. At this time, the region of plasma membrane
in close proximity to the nucleus yields to form a small
extrusionthatincludesaportionofthenucleus.Wespeculate
that vesicle traﬃcking and other protein-sorting pathways
provide additional membrane to the pyrenocyte region,
allowingexpansionandfurtherextrusionofthenucleus.The
subsequent formation and coalescence of U-shaped channels
and vesicles that have accumulated in the region between the
nucleus and incipient reticulocyte allows for separation of
the reticulocyte from the pyrenocyte. In vivo, this process
is likely complemented by attachment of the pyrenocyte
to a nearby macrophage coupled with actin-mediated
movement of the reticulocyte away from the pyrenocyte.
Thus, multiple pathways, including chromatin condensa-
tion, actomyosin motors, and vesicle traﬃcking work in
concert to ensure orchestrated terminal maturation of red
cells.
5. FutureDirections
Although there have been many advances in the past decade,
several aspects of enucleation remain unclear. First, what
are the signaling pathways that trigger enucleation in vivo
and in vitro? Second, what, if any, factors determine polarity
in enucleating cells? Third, what are the contributions of
macrophages and how can these cells be harnessed to
improve ex vivo enucleation? Finally, which motor proteins
are responsible for coordinating the movement of the
nucleus and cytoplasmic vesicles? It is likely that these
questions will be answered in the next decade of research.
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